Coinfections among hospitalized patients with covid-19 in the first pandemic wave
Published by Elsevier Inc..
BACKGROUND: COVID19 is the novel respiratory illness caused by SARS-CoV-2. The presence of other potentially pathogenic microorganisms could worsen the prognosis of these patients.
AIM: The study aims to describe coinfections in COVID-19 patients and contrast it between standard ward and critical care patients at Hospital Central de la Defensa Gómez Ulla (HCDGU).
METHODS: A retrospective study was carried out of patients with COVID-19 confirmed with RTPCR admitted to the HCDGU from March 5, 2020 to May 7 of 2020.
FINDINGS: Of a total of 703 patients with COVID-19, 75(10.7%) had other microbiologically confirmed infections: 9% (58/648) in standard ward patients and 31.5%(17/54) in critical care patients. In total 86 samples of the 75 patients presented some microorganism; clinically relevant bacteraemias, 50%, respiratory cultures, 32.6% and pneumococcal positive antigens, 17.4%.
CONCLUSIONS: We found a low frequency of microorganism coinfection in COVID-19 patients, however in critical care these coinfections increased considerably.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
---|---|
Enthalten in: |
Diagnostic microbiology and infectious disease - 101(2021), 3 vom: 10. Nov., Seite 115416 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zamora-Cintas, María Isabel [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 13.10.2021 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.diagmicrobio.2021.115416 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM329348299 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329348299 | ||
003 | DE-627 | ||
005 | 20231225204923.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.diagmicrobio.2021.115416 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM329348299 | ||
035 | |a (NLM)34391076 | ||
035 | |a (PII)S0732-8893(21)00109-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zamora-Cintas, María Isabel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Coinfections among hospitalized patients with covid-19 in the first pandemic wave |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.10.2021 | ||
500 | |a Date Revised 21.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Published by Elsevier Inc. | ||
520 | |a BACKGROUND: COVID19 is the novel respiratory illness caused by SARS-CoV-2. The presence of other potentially pathogenic microorganisms could worsen the prognosis of these patients | ||
520 | |a AIM: The study aims to describe coinfections in COVID-19 patients and contrast it between standard ward and critical care patients at Hospital Central de la Defensa Gómez Ulla (HCDGU) | ||
520 | |a METHODS: A retrospective study was carried out of patients with COVID-19 confirmed with RTPCR admitted to the HCDGU from March 5, 2020 to May 7 of 2020 | ||
520 | |a FINDINGS: Of a total of 703 patients with COVID-19, 75(10.7%) had other microbiologically confirmed infections: 9% (58/648) in standard ward patients and 31.5%(17/54) in critical care patients. In total 86 samples of the 75 patients presented some microorganism; clinically relevant bacteraemias, 50%, respiratory cultures, 32.6% and pneumococcal positive antigens, 17.4% | ||
520 | |a CONCLUSIONS: We found a low frequency of microorganism coinfection in COVID-19 patients, however in critical care these coinfections increased considerably | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a coinfection | |
650 | 4 | |a hospitalized patients | |
650 | 4 | |a microorganisms | |
700 | 1 | |a López, Diana Jiménez |e verfasserin |4 aut | |
700 | 1 | |a Blanco, Ana Collazos |e verfasserin |4 aut | |
700 | 1 | |a Rodriguez, Tamara Martín |e verfasserin |4 aut | |
700 | 1 | |a Segarra, Javier Mombiedro |e verfasserin |4 aut | |
700 | 1 | |a Novales, Javier Membrillo |e verfasserin |4 aut | |
700 | 1 | |a Ferriol, María Francisca Ramos |e verfasserin |4 aut | |
700 | 1 | |a Maestre, Maria Mateo |e verfasserin |4 aut | |
700 | 1 | |a Sacristán, María Simón |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostic microbiology and infectious disease |d 1986 |g 101(2021), 3 vom: 10. Nov., Seite 115416 |w (DE-627)NLM01262845X |x 1879-0070 |7 nnns |
773 | 1 | 8 | |g volume:101 |g year:2021 |g number:3 |g day:10 |g month:11 |g pages:115416 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diagmicrobio.2021.115416 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 101 |j 2021 |e 3 |b 10 |c 11 |h 115416 |